Table: Phoenixbio - 9-MTH group results

PhoenixBio

14/02/2022 06:30

Feb 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2021        Dec 31, 2020      Mar 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            933 mln             501 mln            1.30      
                                     (-39.8 pct)                    
  Operating     loss 172 mln        loss 363 mln      loss 155 mln  
  Recurring     loss 158 mln        loss 336 mln      loss 156 mln  
  Net           loss 161 mln        loss 347 mln      loss 157 mln  
  EPS          loss 49.01 yen      loss 108.00 yen   loss 47.69 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T